Osteogenon in Orthopedics and Traumatology

PHASE4RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

February 2, 2027

Study Completion Date

December 30, 2027

Conditions
Patients With Fractures
Interventions
DRUG

received an ossein-hydroxyapatite complex

Patients in the study group with fractures received an ossein-hydroxyapatite complex (830 mg of ossein-and-hydroxyapatite complex, with 444 mg of hydroxyapatite, equivalent to 178 mg of calcium and 82 mg of phosphorus) throughout the entire period following fracture healing. The tablets were taken orally, one tablet twice daily.

Trial Locations (1)

46-020

RECRUITING

University Clinical Hospital in Opole, Opole

All Listed Sponsors
lead

University of Opole

OTHER